To assess the performance of a Deep Neural Network (DNN)-based prototype algorithm for automated PE detection on CTPA scans.

Patients who had previously undergone CTPA with three different systems (SOMATOM Force, go.Top, and Definition AS; Siemens Healthineers, Forchheim, Germany) because of suspected PE from September 2022 to January 2023 were retrospectively enrolled in this study (n = 1,000, 58.8 % women). For detailed evaluation, all PE were divided into three location-based subgroups: central arteries, lobar branches, and peripheral regions. Clinical reports served as ground truth. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were determined to evaluate the performance of DNN-based PE detection.

Cases were excluded due to incomplete data (n = 32), inconclusive report (n = 17), insufficient contrast detected in the pulmonary trunk (n = 40), or failure of the preprocessing algorithms (n = 8). Therefore, the final cohort included 903 cases with a PE prevalence of 12 % (n = 110). The model achieved a sensitivity, specificity, PPV, and NPV of 84.6, 95.1, 70.5, and 97.8 %, respectively, and delivered an overall accuracy of 93.8 %. Among the false positive cases (n = 39), common sources of error included lung masses, pneumonia, and contrast flow artifacts. Common sources of false negatives (n = 17) included chronic and subsegmental PEs.

The proposed DNN-based algorithm provides excellent performance for the detection of PE, suggesting its potential utility to support radiologists in clinical reading and exam prioritization.

Deep learning (DL)-based methods show promise in detecting pulmonary embolism (PE) on CT pulmonary angiography (CTPA), potentially improving diagnostic accuracy and workflow efficiency. This meta-analysis aimed to (1) determine pooled performance estimates of DL algorithms for PE detection; and (2) compare the diagnostic efficacy of convolutional neural network (CNN)- versus U-Net-based architectures.

Following PRISMA guidelines, we searched PubMed and EMBASE through April 15, 2025 for English-language studies (2010-2025) reporting DL models for PE detection with extractable 2 × 2 data or performance metrics. True/false positives and negatives were reconstructed when necessary under an assumed 50 % PE prevalence (with 0.5 continuity correction). We approximated AUROC as the mean of sensitivity and specificity if not directly reported. Sensitivity, specificity, accuracy, PPV and NPV were pooled using a DerSimonian-Laird random-effects model with Freeman-Tukey transformation; AUROC values were combined via a fixed-effect inverse-variance approach. Heterogeneity was assessed by Cochran's Q and I2. Subgroup analyses contrasted CNN versus U-Net models.

Twenty-four studies (n = 22,984 patients) met inclusion criteria. Pooled estimates were: AUROC 0.895 (95 % CI: 0.874-0.917), sensitivity 0.894 (0.856-0.923), specificity 0.871 (0.831-0.903), accuracy 0.857 (0.833-0.882), PPV 0.832 (0.794-0.869) and NPV 0.902 (0.874-0.929). Between-study heterogeneity was high (I2 ≈ 97 % for sensitivity/specificity). U-Net models exhibited higher sensitivity (0.899 vs 0.893) and CNN models higher specificity (0.926 vs 0.900); subgroup Q-tests confirmed significant differences for both sensitivity (p = 0.0002) and specificity (p < 0.001).

DL algorithms demonstrate high diagnostic accuracy for PE detection on CTPA, with complementary strengths: U-Net architectures excel in true-positive identification, whereas CNNs yield fewer false positives. However, marked heterogeneity underscores the need for standardized, prospective validation before routine clinical implementation.

Pulmonary perfusion imaging is a key lung health indicator with clinical utility as a diagnostic and treatment planning tool. However, current nuclear medicine modalities face challenges like low spatial resolution and long acquisition times which limit clinical utility to non-emergency settings and often placing extra financial burden on the patient. This study introduces a novel deep learning approach to predict perfusion imaging from non-contrast inhale and exhale computed tomography scans (IE-CT).

We developed a U-Net Transformer architecture modified for Siamese IE-CT inputs, integrating insights from physical models and utilizing a self-supervised learning strategy tailored for lung function prediction. We aggregated 523 IE-CT images from nine different 4DCT imaging datasets for self-supervised training, aiming to learn a low-dimensional IE-CT feature space by reconstructing image volumes from random data augmentations. Supervised training for perfusion prediction used this feature space and transfer learning on a cohort of 44 patients who had both IE-CT and single-photon emission CT (SPECT/CT) perfusion scans.

Testing with random bootstrapping, we estimated the mean and standard deviation of the spatial Spearman correlation between our predictions and the ground truth (SPECT perfusion) to be 0.742 ± 0.037, with a mean median correlation of 0.792 ± 0.036. These results represent a new state-of-the-art accuracy for predicting perfusion imaging from non-contrast CT.

Our approach combines low-dimensional feature representations of both inhale and exhale images into a deep learning model, aligning with previous physical modeling methods for characterizing perfusion from IE-CT. This likely contributes to the high spatial correlation with ground truth. With further development, our method could provide faster and more accurate lung function imaging, potentially expanding its clinical applications beyond what is currently possible with nuclear medicine.

[18F]FDG PET/CT is a powerful imaging modality of high performance in multiple myeloma (MM) and is considered the appropriate method for assessing treatment response in this disease. On the other hand, due to the heterogeneous and sometimes complex patterns of bone marrow infiltration in MM, the interpretation of PET/CT can be particularly challenging, hampering interobserver reproducibility and limiting the diagnostic and prognostic ability of the modality. Although many approaches have been developed to address the issue of standardization, none can yet be considered a standard method for interpretation or objective quantification of PET/CT. Therefore, advanced diagnostic quantification approaches are needed to support and potentially guide the management of MM. In recent years, radiomics has emerged as an innovative method for high-throughput mining of image-derived features for clinical decision making, which may be particularly helpful in oncology. In addition, machine learning and deep learning, both subfields of artificial intelligence (AI) closely related to the radiomics process, have been increasingly applied to automated image analysis, offering new possibilities for a standardized evaluation of imaging modalities such as CT, PET/CT and MRI in oncology. In line with this, the initial but steadily growing literature on the application of radiomics and AI-based methods in the field of [18F]FDG PET/CT in MM has already yielded encouraging results, offering a potentially reliable tool towards optimization and standardization of interpretation in this disease. The main results of these studies are presented in this review.

Artificial intelligence is rapidly transforming quality assurance in healthcare, driving advancements in diagnostics, surgery, and patient care. This review presents a comprehensive analysis of artificial intelligence integration-particularly convolutional and recurrent neural networks-across key clinical domains, significantly enhancing diagnostic accuracy, surgical performance, and pathology evaluation. Artificial intelligence-based approaches have demonstrated clear superiority over conventional methods: convolutional neural networks achieved 91.56% accuracy in scanner fault detection, surpassing manual inspections; endoscopic lesion detection sensitivity rose from 2.3% to 6.1% with artificial intelligence assistance; and gastric cancer invasion depth classification reached 89.16% accuracy, outperforming human endoscopists by 17.25%. In pathology, artificial intelligence achieved 93.2% accuracy in identifying out-of-focus regions and an F1 score of 0.94 in lymphocyte quantification, promoting faster and more reliable diagnostics. Similarly, artificial intelligence improved surgical workflow recognition with over 81% accuracy and exceeded 95% accuracy in skill assessment classification. Beyond traditional diagnostics and surgical support, AI-powered wearable sensors, drug delivery systems, and biointegrated devices are advancing personalized treatment by optimizing physiological monitoring, automating care protocols, and enhancing therapeutic precision. Despite these achievements, challenges remain in areas such as data standardization, ethical governance, and model generalizability. Overall, the findings underscore artificial intelligence's potential to outperform traditional techniques across multiple parameters, emphasizing the need for continued development, rigorous clinical validation, and interdisciplinary collaboration to fully realize its role in precision medicine and patient safety.

Pulmonary embolism (PE) is a significant cause of mortality in the United States. The objective of this study is to implement deep learning (DL) models using computed tomography pulmonary angiography (CTPA), clinical data, and PE Severity Index (PESI) scores to predict PE survival.

In total, 918 patients (median age 64 y, range 13 to 99 y, 48% male) with 3978 CTPAs were identified via retrospective review across 3 institutions. To predict survival, an AI model was used to extract disease-related imaging features from CTPAs. Imaging features and clinical variables were then incorporated into independent DL models to predict survival outcomes. Cross-modal fusion CoxPH models were used to develop multimodal models from combinations of DL models and calculated PESI scores. Five multimodal models were developed as follows: (1) using CTPA imaging features only, (2) using clinical variables only, (3) using both CTPA and clinical variables, (4) using CTPA and PESI score, and (5) using CTPA, clinical variables, and PESI score. Performance was evaluated using the concordance index (c-index). Kaplan-Meier analysis was performed to stratify patients into high-risk and low-risk groups. Additional factor-risk analysis was conducted to account for right ventricular (RV) dysfunction.

For both data sets, the multimodal models incorporating CTPA features, clinical variables, and PESI score achieved higher c-indices than PESI alone. Following the stratification of patients into high-risk and low-risk groups by models, survival outcomes differed significantly (both P<0.001). A strong correlation was found between high-risk grouping and RV dysfunction.

Multiomic DL models incorporating CTPA features, clinical data, and PESI achieved higher c-indices than PESI alone for PE survival prediction.

Thoracic radiology has emerged as a primary field in which artificial intelligence (AI) is extensively researched. Recent advancements highlight the potential to enhance radiologists' performance through AI. AI aids in detecting and classifying abnormalities, and in quantifying both normal and abnormal anatomical structures. Additionally, it facilitates prognostication by leveraging these quantitative values. This review article will discuss the recent achievements of AI in thoracic radiology, focusing primarily on deep learning, and explore the current limitations and future directions of this cutting-edge technique.

Pulmonary embolism (PE) remains a critical condition with significant mortality and morbidity, necessitating timely detection and intervention to improve patient outcomes. This review examines the evolving role of artificial intelligence (AI) in PE management. Two primary AI-driven models that are currently being explored are deep convolutional neural networks (DCNNs) for enhanced image-based detection and natural language processing (NLP) for improved risk stratification using electronic health records. A major advancement in this field was the FDA approval of the Aidoc© AI model, which has demonstrated high specificity and negative predictive value in PE diagnosis from imaging scans. Additionally, AI is being explored for optimizing anticoagulation strategies and predicting PE recurrence risk. While further large-scale studies are needed to fully establish AI's role in clinical practice, its integration holds significant potential to enhance diagnostic accuracy and overall patient management.

Over the past decade, Investigative Radiology has published numerous studies that have fundamentally advanced the field of thoracic imaging. This review summarizes key developments in imaging modalities, computational tools, and clinical applications, highlighting major breakthroughs in thoracic diseases-lung cancer, pulmonary nodules, interstitial lung disease (ILD), chronic obstructive pulmonary disease (COPD), COVID-19 pneumonia, and pulmonary embolism-and outlining future directions.Artificial intelligence (AI)-driven computer-aided detection systems and radiomic analyses have notably improved the detection and classification of pulmonary nodules, while photon-counting detector CT (PCD-CT) and low-field MRI offer enhanced resolution or radiation-free strategies. For lung cancer, CT texture analysis and perfusion imaging refine prognostication and therapy planning. ILD assessment benefits from automated diagnostic tools and innovative imaging techniques, such as PCD-CT and functional MRI, which reduce the need for invasive diagnostic procedures while improving accuracy. In COPD, dual-energy CT-based ventilation/perfusion assessment and dark-field radiography enable earlier detection and staging of emphysema, complemented by deep learning approaches for improved quantification. COVID-19 research has underscored the clinical utility of chest CT, radiographs, and AI-based algorithms for rapid triage, disease severity evaluation, and follow-up. Furthermore, tuberculosis remains a significant global health concern, highlighting the importance of AI-assisted chest radiography for early detection and management. Meanwhile, advances in CT pulmonary angiography, including dual-energy reconstructions, allow more sensitive detection of pulmonary emboli.Collectively, these innovations demonstrate the power of merging novel imaging technologies, quantitative functional analysis, and AI-driven tools to transform thoracic disease management. Ongoing progress promises more precise and personalized diagnostic and therapeutic strategies for diverse thoracic diseases.

Computed tomography pulmonary angiography (CTPA) is an essential diagnostic tool for identifying pulmonary embolism (PE). The integration of AI has significantly advanced CTPA-based PE detection, enhancing diagnostic accuracy and efficiency. This review investigates the growing role of AI in the diagnosis of pulmonary embolism using CTPA imaging. The review examines the capabilities of AI algorithms, particularly deep learning models, in analyzing CTPA images for PE detection. It assesses their sensitivity and specificity compared to human radiologists. AI systems, using large datasets and complex neural networks, demonstrate remarkable proficiency in identifying subtle signs of PE, aiding clinicians in timely and accurate diagnosis. In addition, AI-powered CTPA analysis shows promise in risk stratification, prognosis prediction, and treatment optimization for PE patients. Automated image interpretation and quantitative analysis facilitate rapid triage of suspected cases, enabling prompt intervention and reducing diagnostic delays. Despite these advancements, several limitations remain, including algorithm bias, interpretability issues, and the necessity for rigorous validation, which hinder widespread adoption in clinical practice. Furthermore, integrating AI into existing healthcare systems requires careful consideration of regulatory, ethical, and legal implications. In conclusion, AI-driven CTPA-based PE detection presents unprecedented opportunities to enhance diagnostic precision and efficiency. However, addressing the associated limitations is critical for safe and effective implementation in routine clinical practice. Successful utilization of AI in revolutionizing PE care necessitates close collaboration among researchers, medical professionals, and regulatory organizations.

Pulmonary embolism is a life-threatening condition where early diagnosis and precise localization are crucial for improving patient outcomes. While CT pulmonary angiography (CTPA) is the primary method for detecting pulmonary embolism, existing segmentation algorithms struggle to effectively distinguish thrombi from vascular structures in complex 3D CTPA images, often leading to both false positives and false negatives. To address these challenges, the Threshold Adjustment Segmentation Network (TSNet) is proposed to enhance segmentation performance in 3D CTPA images. TSNet incorporates two core modules: the Threshold Adjustment Module (TAD) and the Geometric-Topological Axial Feature Module (GT-AFM). TAD utilizes logarithmic scaling, adaptive adjustments, and nonlinear transformations to optimize the probability distributions of thrombi and vessels, reducing false positives while improving the sensitivity of thrombus detection. GT-AFM integrates geometric features and topological information to enhance the recognition of complex vascular and thrombotic structures, improving spatial feature processing. Experimental results show that TSNet achieves a sensitivity of 0.761 and a false positives per scan of 1.273 at ε = 0 mm. With an increased tolerance of ε = 5 mm, sensitivity improves to 0.878 and false positives per scan decreases to 0.515, significantly reducing false positives. These results indicate that TSNet demonstrates superior segmentation performance under various tolerance levels, showing robustness and a well-balanced trade-off between sensitivity and false positives, making it highly promising for clinical applications.

Computer vision has emerged as a promising technology with numerous applications in healthcare. This systematic review provides an overview of advancements and challenges associated with computer vision in healthcare. The review highlights the application areas where computer vision has made significant strides, including medical imaging, surgical assistance, remote patient monitoring, and telehealth. Additionally, it addresses the challenges related to data quality, privacy, model interpretability, and integration with existing healthcare systems. Ethical and legal considerations, such as patient consent and algorithmic bias, are also discussed. The review concludes by identifying future directions and opportunities for research, emphasizing the potential impact of computer vision on healthcare delivery and outcomes. Overall, this systematic review underscores the importance of understanding both the advancements and challenges in computer vision to facilitate its responsible implementation in healthcare.

To explore the predictive value of traditional machine learning (ML) and deep learning (DL) algorithms based on computed tomography pulmonary angiography (CTPA) images for short-term adverse outcomes in patients with acute pulmonary embolism (APE). This retrospective study enrolled 132 patients with APE confirmed by CTPA. Thrombus segmentation and texture feature extraction was performed using 3D-Slicer software. The least absolute shrinkage and selection operator (LASSO) algorithm was used for feature dimensionality reduction and selection, with optimal λ values determined using leave-one-fold cross-validation to identify texture features with non-zero coefficients. ML models (logistic regression, random forest, decision tree, support vector machine) and DL models (ResNet 50 and Vgg 19) were used to construct the prediction models. Model performance was evaluated using receiver operating characteristic (ROC) curves and the area under the curve (AUC). The cohort included 84 patients in the good prognosis group and 48 patients in the poor prognosis group. Univariate and multivariate logistic regression analyses showed that diabetes, RV/LV ≥ 1.0, and Qanadli index form independent risk factors predicting poor prognosis in patients with APE(P < 0.05). A total of 750 texture features were extracted, with 4 key features identified through screening. There was a weak positive correlation between texture features and clinical parameters. ROC curves analysis demonstrated AUC values of 0.85 (0.78-0.92), 0.76 (0.67-0.84), and 0.89 (0.83-0.95) for the clinical, texture feature, and combined models, respectively. In the ML models, the random forest model achieved the highest AUC (0.85), and the support vector machine model achieved the lowest AUC (0.62). And the AUCs for the DL models (ResNet 50 and Vgg 19) were 0.91 (95%CI: 0.90-0.92) and 0.94(95%CI: 0.93-0.95), respectively. Vgg 19 model demonstrated exceptional precision (0.93), recall (0.76), specificity (0.95) and F1 score (0.84). Both ML and DL models based on thrombus texture features from CTPA images demonstrated higher predictive efficacy for short-term adverse outcomes in patients with APE, especially the random forest and Vgg 19 models, potentially assisting clinical management in timely interventions to improve patient prognosis.

Introducing deep learning technologies into the medical image processing field requires accuracy guarantee, especially for high-resolution images relayed through endoscopes. Moreover, works relying on supervised learning are powerless in the case of inadequate labeled samples. Therefore, for end-to-end medical image detection with overcritical efficiency and accuracy in endoscope detection, an ensemble-learning-based model with a semi-supervised mechanism is developed in this work. To gain a more accurate result through multiple detection models, we propose a new ensemble mechanism, termed alternative adaptive boosting method (Al-Adaboost), combining the decision-making of two hierarchical models. Specifically, the proposal consists of two modules. One is a local region proposal model with attentive temporal-spatial pathways for bounding box regression and classification, and the other one is a recurrent attention model (RAM) to provide more precise inferences for further classification according to the regression result. The proposal Al-Adaboost will adjust the weights of labeled samples and the two classifiers adaptively, and the nonlabel samples are assigned pseudolabels by our model. We investigate the performance of Al-Adaboost on both the colonoscopy and laryngoscopy data coming from CVC-ClinicDB and the affiliated hospital of Kaohsiung Medical University. The experimental results prove the feasibility and superiority of our model.

Pulmonary embolism (PE) is a clinically challenging diagnosis that varies from silent to life-threatening symptoms. Timely diagnosis of the condition is subject to clinical assessment, D-dimer testing and radiological imaging. Computed tomography pulmonary angiogram (CTPA) is considered the gold standard imaging modality, although some cases can be missed due to reader dependency, resulting in adverse patient outcomes. Hence, it is crucial to implement faster and precise diagnostic strategies to help clinicians diagnose and treat PE patients promptly and mitigate morbidity and mortality. Machine learning (ML) and artificial intelligence (AI) are the newly emerging tools in the medical field, including in radiological imaging, potentially improving diagnostic efficacy. Our review of the studies showed that computer-aided design (CAD) and AI tools displayed similar to superior sensitivity and specificity in identifying PE on CTPA as compared to radiologists. Several tools demonstrated the potential in identifying minor PE on radiological scans showing promising ability to aid clinicians in reducing missed cases substantially. However, it is imperative to design sophisticated tools and conduct large clinical trials to integrate AI use in everyday clinical setting and establish guidelines for its ethical applicability. ML and AI can also potentially help physicians in formulating individualized management strategies to enhance patient outcomes.

The high incidence of venous thromboembolism (VTE) globally and the morbidity and mortality burden associated with the disease make it a pressing issue. Machine learning (ML) can improve VTE prevention, detection, and treatment. The ability of this novel technology to process large amounts of high-dimensional data can help identify new risk factors and better risk stratify patients for thromboprophylaxis. Applications of ML for VTE include systems that interpret medical imaging, assess the severity of the VTE, tailor treatment according to individual patient needs, and identify VTE cases to facilitate surveillance. Generative artificial intelligence may be leveraged to design new molecules such as new anticoagulants, generate synthetic data to expand datasets, and reduce clinical burden by assisting in generating clinical notes. Potential challenges in the applications of these novel technologies include the availability of multidimensional large datasets, prospective studies and clinical trials to ensure safety and efficacy, continuous quality assessment to maintain algorithm accuracy, mitigation of unwanted bias, and regulatory and legal guardrails to protect patients and providers. We propose a practical approach for clinicians to integrate ML into research, from choosing appropriate problems to integrating ML into clinical workflows. ML offers much promise and opportunity for clinicians and researchers in VTE to translate this technology into the clinic and directly benefit the patients.

Pulmonary Embolism (PE) is a life-threatening clinical disease with no specific clinical symptoms and Computed Tomography Angiography (CTA) is used for diagnosis. Clinical decision support scoring systems like Wells and rGeneva based on PE risk factors have been developed to estimate the pre-test probability but are underused, leading to continuous overuse of CTA imaging. This diagnostic study aimed to propose a novel approach for efficient management of PE diagnosis using a two-step interconnected machine learning framework directly by analyzing patients' Electronic Health Records data. First, we performed feature importance analysis according to the result of LightGBM superiority for PE prediction, then four state-of-the-art machine learning methods were applied for PE prediction based on the feature importance results, enabling swift and accurate pre-test diagnosis. Throughout the study patients' data from different departments were collected from Sina educational hospital, affiliated with the Tehran University of medical sciences in Iran. Generally, the Ridge classification method obtained the best performance with an F1 score of 0.96. Extensive experimental findings showed the effectiveness and simplicity of this diagnostic process of PE in comparison with the existing scoring systems. The main strength of this approach centered on PE disease management procedures, which would reduce avoidable invasive CTA imaging and be applied as a primary prognosis of PE, hence assisting the healthcare system, clinicians, and patients by reducing costs and promoting treatment quality and patient satisfaction.

Acute aortic dissection (AD) is a life-threatening condition in which early detection can significantly improve patient outcomes and survival. This study evaluates the clinical benefits of integrating a deep learning (DL)-based application for the automated detection and prioritization of AD on chest CT angiographies (CTAs) with a focus on the reduction in the scan-to-assessment time (STAT) and interpretation time (IT).

This retrospective Multi-Reader Multi-Case (MRMC) study compared AD detection with and without artificial intelligence (AI) assistance. The ground truth was established by two U.S. board-certified radiologists, while three additional expert radiologists served as readers. Each reader assessed the same CTAs in two phases: assessment unaided by AI assistance (pre-AI arm) and, after a 1-month washout period, assessment aided by device outputs (post-AI arm). STAT and IT metrics were compared between the two arms.

This study included 285 CTAs (95 per reader, per arm) with a mean patient age of 58.5 years ±14.7 (SD), of which 52% were male and 37% had a prevalence of AD. AI assistance significantly reduced the STAT for detecting 33 true positive AD cases from 15.84 min (95% CI: 13.37-18.31 min) without AI to 5.07 min (95% CI: 4.23-5.91 min) with AI, representing a 68% reduction (p < 0.01). The IT also reduced significantly from 21.22 s (95% CI: 19.87-22.58 s) without AI to 14.17 s (95% CI: 13.39-14.95 s) with AI (p < 0.05).

The integration of a DL-based algorithm for AD detection on chest CTAs significantly reduces both the STAT and IT. By prioritizing urgent cases, the AI-assisted approach outperforms the standard First-In, First-Out (FIFO) workflow.

To retrospectively evaluate the trends in utilization and results of computed tomography pulmonary angiography (CTPA study) for detection of acute pulmonary embolism (PE) in the hospital inpatients during different phases of COVID-19 public health emergency. We conducted an Institutional Review Board (IRB)-approved retrospective review of CTPA studies for our hospital inpatients in the years from 2019 to 2023, ranging from the prepandemic year (2019) to the year coinciding with the end of public health declarations (2023). Collected characteristics included patient age, patient sex, and result of the study. The utilization of CTPA studies for inpatients was higher in 2020 to 2023, compared to 2019 (3.8% in 2023 compared to 2.4% in 2019, P < .001). The increase in utilization was also statistically significant in each group, when stratified by age and sex (OR = 1.46 for female, OR = 1.71 for male, OR = 1.93 for elderly, and OR = 1.29 for non-elderly inpatients in 2023, compared to 2019). The positivity rate of acute PE in the inpatients was overall higher in 2021, 2022, and 2023, compared to 2019 (for example, 18.5% in 2023 compared to 14.3% in 2019, P = .01). When stratified by age and sex, only the non-elderly patients continued to have a significantly higher rate of acute PE in 2023, compared to 2019 (OR = 1.39). While studies spanning longer time frames and involving multiple institutions are needed to understand and generalize this conclusion, we conclude that the utilization and positivity rates of CTPA studies in inpatients remains high at the end of the COVID-19 pandemic public health emergency.

The incidence of venous thromboembolism is estimated to be around 3% of cancer patients. However, a majority of incidental pulmonary embolism (iPE) can be overlooked by radiologists in asymptomatic patients, performing CT scans for disease surveillance, which may significantly impact the patient's health and management. Routine imaging in oncology is usually reviewed with delayed hours after the acquisition of images. Nevertheless, the advent of AI in radiology could reduce the risk of the diagnostic delay of iPE by an optimal triage immediately at the acquisition console. This study aimed to determine the accuracy rate of an AI algorithm (CINA-iPE) in detecting iPE and the duration until the management of cancer patients in our center, in addition to describing the characteristics of patients with a confirmed pulmonary embolism (PE).

This is a retrospective analysis of the role of Avicenna's CE-certified and FDA-cleared CINA-iPE algorithm in oncology patients treated at Gustave Roussy Cancer Campus. The results obtained from the AI algorithm were compared with the attending radiologist's report and were analyzed by both a radiology resident and a senior radiologist. In case of any discordant results, the reason for this discrepancy was further investigated. The duration between the exact time of the CT scan and analysis was assessed, as well as the duration from the result's report and the start of active management.

Out of 3047 patients, 104 alerts were detected for iPE (prevalence of 1.3%), while 2942 had negative findings. In total, 36 of the 104 patients had confirmed PE, while 68 alerts were false positives. Only one patient reported as negative by the AI tool was deemed to have a PE by the radiologist. The sensitivity and specificity of the AI model were 97.3% and 97.74%, while the PPV and NPV were 34.62% and 99.97%, respectively. Most causes of FP were artifacts (22 cases, 32.3%) and lymph nodes (11 cases, 16.2%). Seven patients experienced delayed diagnosis, requiring them to return to the ER for treatment after being sent home following their scan. The remaining patients received prompt care immediately after their testing, with a mean delay time of 8.13 h.

The addition of an AI system for the detection of unsuspected PEs on chest CT scans in routine oncology care demonstrated a promising efficacy in comparison to human performance. Despite a low prevalence, the sensitivity and specificity of the AI tool reached 97.3% and 97.7%, respectively, with detection of all the reported clinical PEs, except one single case. This study describes the potential synergy between AI and radiologists for an optimal diagnosis of iPE in routine clinical cancer care.

In the oncology field, iPEs are common, with an increased risk of morbidity when missed with a delayed diagnosis. With the assistance of a reliable AI tool, the radiologist can focus on the challenging analysis of oncology results while dealing with urgent diagnosis such as PE by sending the patient straight to the ER (Emergency Room) for prompt treatment.

Artificial intelligence (AI) has the potential to fundamentally change radiology workflow.

This review article provides an overview of AI applications in cardiovascular radiology with a focus on image acquisition, image reconstruction, and workflow optimization.

First, established applications of AI are presented for cardiovascular computed tomography (CT) and magnetic resonance imaging (MRI). Building on this, we describe the range of applications that are currently being developed and evaluated. The practical benefits, opportunities, and potential risks of artificial intelligence in cardiovascular imaging are critically discussed. The presentation is based on the relevant specialist literature and our own clinical and scientific experience.

AI-based techniques for image reconstruction are already commercially available and enable dose reduction in cardiovascular CT and accelerated image acquisition in cardiac MRI. Postprocessing of cardiovascular CT and MRI examinations can already be considerably simplified using established AI-based segmentation algorithms. In contrast, the practical benefits of many AI applications aimed at the diagnosis of cardiovascular diseases are less evident. Potential risks such as automation bias and considerations regarding cost efficiency should also be taken into account.

In a market characterized by great expectations and rapid technical development, it is important to realistically assess the practical benefits of AI applications for your own hospital or practice.

Pulmonary hypertension is a heterogeneous condition with significant morbidity and mortality. Computer tomography (CT) plays a central role in determining the phenotype of pulmonary hypertension, informing treatment strategies. Many artificial intelligence tools have been developed in this modality for the assessment of pulmonary hypertension. This article reviews the latest CT artificial intelligence applications in pulmonary hypertension and related diseases.

Multistructure segmentation tools have been developed in both pulmonary hypertension and nonpulmonary hypertension cohorts using state-of-the-art UNet architecture. These segmentations correspond well with those of trained radiologists, giving clinically valuable metrics in significantly less time. Artificial intelligence lung parenchymal assessment accurately identifies and quantifies lung disease patterns by integrating multiple radiomic techniques such as texture analysis and classification. This gives valuable information on disease burden and prognosis. There are many accurate artificial intelligence tools to detect acute pulmonary embolism. Detection of chronic pulmonary embolism proves more challenging with further research required.

There are numerous artificial intelligence tools being developed to identify and quantify many clinically relevant parameters in both pulmonary hypertension and related disease cohorts. These potentially provide accurate and efficient clinical information, impacting clinical decision-making.

Diagnosing pulmonary embolism (PE) is still challenging due to other conditions that can mimic its appearance, leading to incomplete or delayed management and several inter-observer variabilities. This study evaluated the performance and clinical utility of an artificial intelligence (AI)-based application designed to assist clinicians in the detection of PE on CT pulmonary angiography (CTPA).

CTPAs from 230 US cities acquired on 57 scanner models from 6 different vendors were retrospectively collected. Three US board certified expert radiologists defined the ground truth by majority agreement. The same cases were analyzed by CINA-PE, an AI-driven algorithm capable of detecting and highlighting suspected PE locations. The algorithm's performance at a per-case and per-finding level was evaluated. Furthermore, cases with PE not mentioned in the clinical report but correctly detected by the algorithm were analyzed.

A total of 1204 CTPAs (mean age 62.1 years ± 16.6[SD], 44.4 % female, 14.9 % positive) were included in the study. Per-case sensitivity and specificity were 93.9 % (95%CI: 89.3 %-96.9 %) and 94.8 % (95%CI: 93.3 %-96.1 %), respectively. Per-finding positive predictive value was 89.5 % (95%CI: 86.7 %-91.9 %). Among the 196 positive cases, 29 (15.6 %) were not mentioned in the clinical report. The algorithm detected 22/29 (76 %) of these cases, leading to a reduction in the miss rate from 15.6 % to 3.8 % (7/186).

The AI-based application may improve diagnostic accuracy in detecting PE and enhance patient outcomes through timely intervention. Integrating AI tools in clinical workflows can reduce missed or delayed diagnoses, and positively impact healthcare delivery and patient care.

Pulmonary Embolism (PE) has diverse manifestations with different etiologies such as venous thromboembolism, septic embolism, and paradoxical embolism. In this study, a novel attention-based multi-task model is proposed for PE segmentation and detection from Computed Tomography Pulmonary Angiography (CTPA) images. A Y-Net architecture is used to implement this model, which facilitates segmentation and classification jointly, improving performance and efficiency. It is leveraged with Multi Head Attention (MHA), which allows the model to focus on important regions of the image while suppressing irrelevant information, improving the accuracy of the segmentation and detection tasks. The proposed PE-YNet model is tested with two public datasets, achieving a maximum mean detection and segmentation accuracy of 99.89% and 99.83%, respectively, on the CAD-PE challenge dataset. Similarly, it also achieves a detection accuracy of 99.75% and a segmentation accuracy of 99.81% on the FUMPE dataset. Additionally, sensitivity analysis also shows a high sensitivity of 0.9885 for the localization error ɛ = 0 for the CAD-PE dataset, demonstrating the model's robustness against false predictions compared to state-of-the-art models. Further, this model also exhibits lower inference time, size, and memory usage compared to representative models. An automated PE-YNet tool can assist physicians with PE diagnosis, treatment, and prognosis monitoring in the clinical management of CoVID-19.

This paper presents an artificial intelligence-based classification model for the detection of pulmonary embolism in computed tomography angiography. The proposed model, developed from public data and validated on a large dataset from a tertiary hospital, uses a two-dimensional approach that integrates temporal series to classify each slice of the examination and make predictions at both slice and examination levels. The training process consists of two stages: first using a convolutional neural network InceptionResNet V2 and then a recurrent neural network long short-term memory model. This approach achieved an accuracy of 93% at the slice level and 77% at the examination level. External validation using a hospital dataset resulted in a precision of 86% for positive pulmonary embolism cases and 69% for negative pulmonary embolism cases. Notably, the model excels in excluding pulmonary embolism, achieving a precision of 73% and a recall of 82%, emphasizing its clinical value in reducing unnecessary interventions. In addition, the diverse demographic distribution in the validation dataset strengthens the model's generalizability. Overall, this model offers promising potential for accurate detection and exclusion of pulmonary embolism, potentially streamlining diagnosis and improving patient outcomes.

CT pulmonary angiography is the gold standard for diagnosing pulmonary embolism, and DL algorithms are being developed to manage the increase in demand. The nnU-Net is a new auto-adaptive DL framework that minimizes manual tuning, making it easier to develop effective algorithms for medical imaging even without specific expertise. This study assesses the performance of a locally developed nnU-Net algorithm on the RSPECT dataset for PE detection, clot volume measurement, and correlation with right ventricle overload.

User input was limited to segmentation using 3DSlicer. We worked with the RSPECT dataset and trained an algorithm from 205 PE and 340 negatives. The test dataset comprised 6573 exams. Performance was tested against PE characteristics, such as central, non-central, and RV overload. Blood clot volume (BCV) was extracted from each exam. We employed ROC curves and logistic regression for statistical validation.

Negative studies had a median BCV of 1 μL, which increased to 345 μL in PE-positive cases and 7,378 μL in central PEs. Statistical analysis confirmed a significant BCV correlation with PE presence, central PE, and increased RV/LV ratio (p < 0.0001). The model's AUC for PE detection was 0.865, with an 83 % accuracy at a 55 μL threshold. Central PE detection AUC was 0.937 with 91 % accuracy at 850 μL. The RV overload AUC stood at 0.848 with 79 % accuracy.

The nnU-Net algorithm demonstrated accurate PE detection, particularly for central PE. BCV is an accurate metric for automated severity stratification and case prioritization.

The nnU-Net framework can be utilized to create a dependable DL for detecting PE. It offers a user-friendly approach to those lacking expertise in AI and rapidly extracts the Blood Clot Volume, a metric that can evaluate the PE's severity.

Acute pulmonary embolism (PE) is a leading cause of cardiovascular death and morbidity, and presents a major burden to healthcare systems. The field has seen rapid growth with development of innovative clot reduction technologies, as well as ongoing multicenter trials that may completely revolutionize care of PE patients. However, current paucity of robust clinical trials and guidelines often leave individual physicians managing patients with acute PE in a dilemma.

The pulmonary embolism response team (PERT) was developed as a platform to rapidly engage multiple specialists to deliver evidence-based, organized and efficient care and help address some of the gaps in knowledge. Several centers investigating outcomes following implementation of PERT have demonstrated shorter hospital and intensive-care unit stays, lower use of inferior vena cava filters, and in some instances improved mortality. Since the advent of PERT, early findings demonstrate promise with improved outcomes after implementation of PERT. Incorporation of artificial intelligence (AI) into PERT has also shown promise with more streamlined care and reducing response times. Further clinical trials are needed to examine the impact of PERT model on care delivery and clinical outcomes.

Diagnosing myocarditis relies on multimodal data, including cardiovascular magnetic resonance (CMR), clinical symptoms, and blood values. The correct interpretation and integration of CMR findings require radiological expertise and knowledge. We aimed to investigate the performance of Generative Pre-trained Transformer 4 (GPT-4), a large language model, for report-based medical decision-making in the context of cardiac MRI for suspected myocarditis.

This retrospective study includes CMR reports from 396 patients with suspected myocarditis and eight centers, respectively. CMR reports and patient data including blood values, age, and further clinical information were provided to GPT-4 and radiologists with 1 (resident 1), 2 (resident 2), and 4 years (resident 3) of experience in CMR and knowledge of the 2018 Lake Louise Criteria. The final impression of the report regarding the radiological assessment of whether myocarditis is present or not was not provided. The performance of Generative pre-trained transformer 4 (GPT-4) and the human readers were compared to a consensus reading (two board-certified radiologists with 8 and 10 years of experience in CMR). Sensitivity, specificity, and accuracy were calculated.

GPT-4 yielded an accuracy of 83%, sensitivity of 90%, and specificity of 78%, which was comparable to the physician with 1 year of experience (R1: 86%, 90%, 84%, p = 0.14) and lower than that of more experienced physicians (R2: 89%, 86%, 91%, p = 0.007 and R3: 91%, 85%, 96%, p < 0.001). GPT-4 and human readers showed a higher diagnostic performance when results from T1- and T2-mapping sequences were part of the reports, for residents 1 and 3 with statistical significance (p = 0.004 and p = 0.02, respectively).

GPT-4 yielded good accuracy for diagnosing myocarditis based on CMR reports in a large dataset from multiple centers and therefore holds the potential to serve as a diagnostic decision-supporting tool in this capacity, particularly for less experienced physicians. Further studies are required to explore the full potential and elucidate educational aspects of the integration of large language models in medical decision-making.

The first-choice imaging test for visualization of thromboemboli in the pulmonary vasculature in patients with suspected acute pulmonary embolism (PE) is multidetector computed tomography pulmonary angiography (CTPA) - a readily available and widely used imaging technique. Through technological advancements over the past years, alternative imaging techniques for the diagnosis of PE have become available, whilst others are still under investigation. In particular, the evolution of artificial intelligence (AI) is expected to enable further innovation in diagnostic management of PE. In this narrative review, current CTPA techniques and the emerging technology photon-counting CT (PCCT), as well as other modern imaging techniques of acute PE are discussed, including CTPA with iodine maps based on subtraction or dual-energy acquisition, single-photon emission CT (SPECT), magnetic resonance angiography (MRA), and magnetic resonance direct thrombus imaging (MRDTI). Furthermore, potential applications of AI are discussed.

To evaluate the trends in utilization and results of computed tomography pulmonary angiography (CTPA study) for detection of acute pulmonary embolism (PE) in the Emergency Department (ED) during different phases of COVID-19 public health emergency.

We conducted a retrospective review of CTPA studies ordered through our ED in the months of March through May during five consecutive years from 2019 to 2023, designated as pre-pandemic, early, ongoing, recovery, and post-pandemic periods respectively. Collected characteristics included patient age, patient sex, and result of the study.

The utilization of CTPA studies for ED patients increased during the early, ongoing, and recovery periods. CTPA study utilization in the post-pandemic period was not significantly different from the pre-pandemic period (p = 0.08). No significant difference in CTPA study utilization was noted in the other periods when stratified by age group or sex, compared to the pre-pandemic period. The positivity rate of acute PE in ED patients was not significantly different in other periods compared to the pre-pandemic period.

At our institution, the utilization and positivity rates of CTPA studies for the ED patients were not significantly different in the post-pandemic period compared to the pre-pandemic period. While studies spanning a larger timeframe and involving multiple institutions are needed to test the applicability of this observation to a wider patient population beyond our defined post-pandemic period, we conclude that our study provides some confidence to the ordering provider and the radiologist in embracing the end of COVID-19 public health emergency by the WHO and the United States HHS with respect to CTPA studies.

Pulmonary Embolisms (PE) represent a leading cause of cardiovascular death. While medical imaging, through computed tomographic pulmonary angiography (CTPA), represents the gold standard for PE diagnosis, it is still susceptible to misdiagnosis or significant diagnosis delays, which may be fatal for critical cases. Despite the recently demonstrated power of deep learning to bring a significant boost in performance in a wide range of medical imaging tasks, there are still very few published researches on automatic pulmonary embolism detection. Herein we introduce a deep learning based approach, which efficiently combines computer vision and deep neural networks for pulmonary embolism detection in CTPA. Our method brings novel contributions along three orthogonal axes: (1) automatic detection of anatomical structures; (2) anatomical aware pretraining, and (3) a dual-hop deep neural net for PE detection. We obtain state-of-the-art results on the publicly available multicenter large-scale RSNA dataset.

Augmenting echocardiography with artificial intelligence would allow for automated assessment of routine parameters and identification of disease patterns not easily recognized otherwise. View classification is an essential first step before deep learning can be applied to the echocardiogram.

We trained two- and three-dimensional convolutional neural networks (CNNs) using transthoracic echocardiographic (TTE) studies obtained from 909 patients to classify nine view categories (10 269 videos). Transthoracic echocardiographic studies from 229 patients were used in internal validation (2582 videos). Convolutional neural networks were tested on 100 patients with comprehensive TTE studies (where the two examples chosen by CNNs as most likely to represent a view were evaluated) and 408 patients with five view categories obtained via point-of-care ultrasound (POCUS). The overall accuracy of the two-dimensional CNN was 96.8%, and the averaged area under the curve (AUC) was 0.997 on the comprehensive TTE testing set; these numbers were 98.4% and 0.998, respectively, on the POCUS set. For the three-dimensional CNN, the accuracy and AUC were 96.3% and 0.998 for full TTE studies and 95.0% and 0.996 on POCUS videos, respectively. The positive predictive value, which defined correctly identified predicted views, was higher with two-dimensional rather than three-dimensional networks, exceeding 93% in apical, short-axis aortic valve, and parasternal long-axis left ventricle views.

An automated view classifier utilizing CNNs was able to classify cardiac views obtained using TTE and POCUS with high accuracy. The view classifier will facilitate the application of deep learning to echocardiography.

To evaluate the diagnostic performance and generalizability of the winning DL algorithm of the RSNA 2020 PE detection challenge to a local population using CTPA data from two hospitals.

Consecutive CTPA images from patients referred for suspected PE were retrospectively analysed. The winning RSNA 2020 DL algorithm was retrained on the RSNA-STR Pulmonary Embolism CT (RSPECT) dataset. The algorithm was tested in hospital A on multidetector CT (MDCT) images of 238 patients and in hospital B on spectral detector CT (SDCT) and virtual monochromatic images (VMI) of 114 patients. The output of the DL algorithm was compared with a reference standard, which included a consensus reading by at least two experienced cardiothoracic radiologists for both hospitals. Areas under the receiver operating characteristic curve (AUCs) were calculated. Sensitivity and specificity were determined using the maximum Youden index.

According to the reference standard, PE was present in 73 patients (30.7%) in hospital A and 33 patients (29.0%) in hospital B. For the DL algorithm the AUC was 0.96 (95% CI 0.92-0.98) in hospital A, 0.89 (95% CI 0.81-0.94) for conventional reconstruction in hospital B and 0.87 (95% CI 0.80-0.93) for VMI.

The RSNA 2020 pulmonary embolism detection on CTPA challenge winning DL algorithm, retrained on the RSPECT dataset, showed high diagnostic accuracy on MDCT images. A somewhat lower performance was observed on SDCT images, which suggest additional training on novel CT technology may improve generalizability of this DL algorithm.

As healthcare systems around the world face challenges such as escalating costs, limited access, and growing demand for personalized care, artificial intelligence (AI) is emerging as a key force for transformation. This review is motivated by the urgent need to harness AI's potential to mitigate these issues and aims to critically assess AI's integration in different healthcare domains. We explore how AI empowers clinical decision-making, optimizes hospital operation and management, refines medical image analysis, and revolutionizes patient care and monitoring through AI-powered wearables. Through several case studies, we review how AI has transformed specific healthcare domains and discuss the remaining challenges and possible solutions. Additionally, we will discuss methodologies for assessing AI healthcare solutions, ethical challenges of AI deployment, and the importance of data privacy and bias mitigation for responsible technology use. By presenting a critical assessment of AI's transformative potential, this review equips researchers with a deeper understanding of AI's current and future impact on healthcare. It encourages an interdisciplinary dialogue between researchers, clinicians, and technologists to navigate the complexities of AI implementation, fostering the development of AI-driven solutions that prioritize ethical standards, equity, and a patient-centered approach.

Hepatic artery thrombosis (HAT) is a devastating vascular complication following liver transplantation, requiring prompt diagnosis and rapid revascularization treatment to prevent graft loss. At present, imaging modalities such as ultrasound, computed tomography, and magnetic resonance play crucial roles in diagnosing HAT. Although imaging techniques have improved sensitivity and specificity for HAT diagnosis, they have limitations that hinder the timely diagnosis of this complication. In this sense, the emergence of artificial intelligence (AI) presents a transformative opportunity to address these diagnostic limitations. The develo pment of machine learning algorithms and deep neural networks has demon strated the potential to enhance the precision diagnosis of liver transplant com plications, enabling quicker and more accurate detection of HAT. This article examines the current landscape of imaging diagnostic techniques for HAT and explores the emerging role of AI in addressing future challenges in the diagnosis of HAT after liver transplant.

Dual-energy CT (DECT) is a non-invasive way to determine the presence of monosodium urate (MSU) crystals in the workup of gout. Color-coding distinguishes MSU from calcium following material decomposition and post-processing. Manually identifying these foci (most commonly labeled green) is tedious, and an automated detection system could streamline the process. This study aims to evaluate the impact of a deep-learning (DL) algorithm developed for detecting green pixelations on DECT on reader time, accuracy, and confidence.

We collected a sample of positive and negative DECTs, reviewed twice-once with and once without the DL tool-with a 2-week washout period. An attending musculoskeletal radiologist and a fellow separately reviewed the cases, simulating clinical workflow. Metrics such as time taken, confidence in diagnosis, and the tool's helpfulness were recorded and statistically analyzed.

We included thirty DECTs from different patients. The DL tool significantly reduced the reading time for the trainee radiologist (p = 0.02), but not for the attending radiologist (p = 0.15). Diagnostic confidence remained unchanged for both (p = 0.45). However, the DL model identified tiny MSU deposits that led to a change in diagnosis in two cases for the in-training radiologist and one case for the attending radiologist. In 3/3 of these cases, the diagnosis was correct when using DL.

The implementation of the developed DL model slightly reduced reading time for our less experienced reader and led to improved diagnostic accuracy. There was no statistically significant difference in diagnostic confidence when studies were interpreted without and with the DL model.

To compare radiology residents' diagnostic performances to detect pulmonary emboli (PEs) on CT pulmonary angiographies (CTPAs) with deep-learning (DL)-based algorithm support and without.

Fully anonymized CTPAs (n = 207) of patients suspected of having acute PE served as input for PE detection using a previously trained and validated DL-based algorithm. Three residents in their first three years of training, blinded to the index report and clinical history, read the CTPAs first without, and 2 months later with the help of artificial intelligence (AI) output, to diagnose PE as present, absent or indeterminate. We evaluated concordances and discordances with the consensus-reading results of two experts in chest imaging.

Because the AI algorithm failed to analyze 11 CTPAs, 196 CTPAs were analyzed; 31 (15.8 %) were PE-positive. Good-classification performance was higher for residents with AI-algorithm support than without (AUROCs: 0.958 [95 % CI: 0.921-0.979] vs. 0.894 [95 % CI: 0.850-0.931], p < 0.001, respectively). The main finding was the increased sensitivity of residents' diagnoses using the AI algorithm (92.5 % vs. 81.7 %, respectively). Concordance between residents (kappa: 0.77 [95 % CI: 0.76-0.78]; p < 0.001) improved with AI-algorithm use (kappa: 0.88 [95 % CI: 0.87-0.89]; p < 0.001).

The AI algorithm we used improved between-resident agreements to interpret CTPAs for suspected PE and, hence, their diagnostic performances.

The contribution of artificial intelligence (AI) to medical imaging is currently the object of widespread experimentation. The development of deep learning (DL) methods, particularly convolution neural networks (CNNs), has led to performance gains often superior to those achieved by conventional methods such as machine learning. Radiomics is an approach aimed at extracting quantitative data not accessible to the human eye from images expressing a disease. The data subsequently feed machine learning models and produce diagnostic or prognostic probabilities. As for the multiple applications of AI methods in thoracic imaging, they are undergoing evaluation. Chest radiography is a practically ideal field for the development of DL algorithms able to automatically interpret X-rays. Current algorithms can detect up to 14 different abnormalities present either in isolation or in combination. Chest CT is another area offering numerous AI applications. Various algorithms have been specifically formed and validated for the detection and characterization of pulmonary nodules and pulmonary embolism, as well as segmentation and quantitative analysis of the extent of diffuse lung diseases (emphysema, infectious pneumonias, interstitial lung disease). In addition, the analysis of medical images can be associated with clinical, biological, and functional data (multi-omics analysis), the objective being to construct predictive approaches regarding disease prognosis and response to treatment.

Cardiovascular CT is being widely used in the diagnosis of cardiovascular disease due to the rapid technological advancements in CT scanning techniques. These advancements include the development of multi-slice CT, from early generation to the latest models, which has the capability of acquiring images with high spatial and temporal resolution. The recent emergence of photon-counting CT has further enhanced CT performance in clinical applications, providing improved spatial and contrast resolution. CT-derived fractional flow reserve is superior to standard CT-based anatomical assessment for the detection of lesion-specific myocardial ischemia. CT-derived 3D-printed patient-specific models are also superior to standard CT, offering advantages in terms of educational value, surgical planning, and the simulation of cardiovascular disease treatment, as well as enhancing doctor-patient communication. Three-dimensional visualization tools including virtual reality, augmented reality, and mixed reality are further advancing the clinical value of cardiovascular CT in cardiovascular disease. With the widespread use of artificial intelligence, machine learning, and deep learning in cardiovascular disease, the diagnostic performance of cardiovascular CT has significantly improved, with promising results being presented in terms of both disease diagnosis and prediction. This review article provides an overview of the applications of cardiovascular CT, covering its performance from the perspective of its diagnostic value based on traditional lumen assessment to the identification of vulnerable lesions for the prediction of disease outcomes with the use of these advanced technologies. The limitations and future prospects of these technologies are also discussed.

Virtual monochromatic images (VMI) are increasingly used in clinical practice as they improve contrast-to-noise ratio. However, due to their different appearances, the performance of artificial intelligence (AI) trained on conventional CT images may worsen. The goal of this study was to assess the performance of an established AI algorithm trained on conventional polychromatic computed tomography (CT) images (CPI) to detect pulmonary embolism (PE) on VMI.

Paired 60 kiloelectron volt (keV) VMI and CPI of 114 consecutive patients suspected of PE, obtained with a detector-based spectral CT scanner, were retrospectively analyzed by an established AI algorithm. The CT pulmonary angiography (CTPA) were classified as positive or negative for PE on a per-patient level. The reference standard was established using a comprehensive method that combined the evaluation of the attending radiologist and three experienced cardiothoracic radiologists aided by two different detection tools. Sensitivity, specificity, positive and negative predictive values and likelihood ratios of the algorithm on VMI and CPI were compared.

The prevalence of PE according to the reference standard was 35.1% (40 patients). None of the diagnostic accuracy measures of the algorithm showed a significant difference between CPI and VMI. Sensitivity was 77.5% (95% confidence interval (CI) 64.6-90.4%) and 85.0% (73.9-96.1%) (p = 0.08) on CPI and VMI respectively and specificity 96.0% (91.4-100.0%) and 94.6% (89.4-99.7%) (p = 0.32).

Diagnostic performance of the AI algorithm that was trained on CPI did not drop on VMI, which is reassuring for its use in clinical practice.

A commercially available AI algorithm, trained on conventional polychromatic CTPA, could be safely used on virtual monochromatic images. This supports the sustainability of AI-aided detection of PE on CT despite ongoing technological advances in medical imaging, although monitoring in daily practice will remain important.

• Diagnostic accuracy of an AI algorithm trained on conventional polychromatic images to detect PE did not drop on virtual monochromatic images. • Our results are reassuring as innovations in hardware and reconstruction in CT are continuing, whilst commercial AI algorithms that are trained on older generation data enter healthcare.

In recent years, there has been remarkable progress in the field of artificial intelligence technology. Artificial intelligence applications have been extensively researched and actively implemented across various domains within healthcare. This study reviews the current state of artificial intelligence research in interventional pulmonology and engages in a discussion to comprehend its capabilities and implications.

Deep learning, a subset of artificial intelligence, has found extensive applications in recent years, enabling highly accurate identification and labeling of bronchial segments solely from intraluminal bronchial images. Furthermore, research has explored the use of artificial intelligence for the analysis of endobronchial ultrasound images, achieving a high degree of accuracy in distinguishing between benign and malignant targets within ultrasound images. These advancements have become possible due to the increased computational power of modern systems and the utilization of vast datasets, facilitating detections and predictions with greater precision and speed.

Artificial intelligence integration into interventional pulmonology has the potential to enhance diagnostic accuracy and patient safety, ultimately leading to improved patient outcomes. However, the clinical impacts of artificial intelligence enhanced procedures remain unassessed. Additional research is necessary to evaluate both the advantages and disadvantages of artificial intelligence in the field of interventional pulmonology.

Computed tomography (CT) imaging of the thorax is widely used for the detection and monitoring of pulmonary embolism (PE). However, CT images can contain artifacts due to the acquisition or the processes involved in image reconstruction. Radiologists often have to distinguish between such artifacts and actual PEs. We provide a proof of concept in the form of a scalable hypothesis testing method for CT, to enable quantifying uncertainty of possible PEs. In particular, we introduce a Bayesian Framework to quantify the uncertainty of an observed compact structure that can be identified as a PE. We assess the ability of the method to operate under high-noise environments and with insufficient data.